Adults with ADHD found to have reduced life expectancy

Adults who have been diagnosed with attention deficit hyperactivity disorder (ADHD) may be living shorter lives than they should, finds a world-first study led by UCL researchers.

Can a GLP-1 Agonist Improve Parkinson’s Symptoms?

An investigational brain-penetrant, pegylated analogue of the glucagon-like peptide-1 (GLP-1) receptor agonist exenatide (Byetta, Bydureon) known as NLY01 did not lead to improvement in Parkinson’s

December 20, 2023

Tyra gains orphan drug status from FDA for achondroplasia therapy

Mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene have been linked to achondroplasia or dwarfism. Credit: LANL (Los Alamos National Lab) /

August 2, 2023

Q2 2024 update: electronic medical record (emr) systems related private equity activity in the pharmaceutical industry

In value terms, electronic medical record (emr) systems-related deal activity remained flat in Q2 2024 compared with the previous quarter and as compared to Q2

August 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.